Avg closing price
Price range

29 Ken Griffin Theravance Biopharma Trades

Ken Griffin acquired 150 Thousand Theravance Biopharma shares worth $1.35 Million. That's 0.00% of their equity portfolio (2581st largest holding). The first Theravance Biopharma trade was made in Q2 2014. Since then Ken Griffin bought shares 25 more times and sold shares on 30 occasions. The investor's estimated purchase price is $1.45 Million, resulting in a loss of 6.5%.

Avg closing price
Price range
Increased shares by 308.8% (+113 Thousand shares) Q4 2023
Avg closing price $10.06
Price range $8.58 - $11.40
Sold 54.7% shares (-44.3 Thousand shares) Q3 2023
Avg closing price $9.65
Price range $8.38 - $10.44
Increased shares by 23.5% (+15.4 Thousand shares) Q2 2023
Avg closing price $11.04
Price range $10.16 - $11.92
Sold 22.3% shares (-18.8 Thousand shares) Q1 2023
Avg closing price $10.57
Price range $9.87 - $11.44
Sold 66.3% shares (-166 Thousand shares) Q4 2022
Avg closing price $10.51
Price range $9.65 - $11.34
Increased shares by 1474.3% (+235 Thousand shares) Q3 2022
Avg closing price $9.37
Price range $8.39 - $10.22
Sold 3.8% shares (-635 shares) Q2 2022
Avg closing price $9.21
Price range $8.41 - $10.34
Increased shares by 55.4% (+5.9 Thousand shares) Q1 2022
Avg closing price $9.80
Price range $8.33 - $12.96
New holding (+10.6 Thousand shares) Q4 2021
Avg closing price $8.72
Price range $7.42 - $11.05
Sold -149 Thousand shares Q1 2021
Avg closing price $19.01
Price range $16.57 - $21.08
Sold 13.0% shares (-22.2 Thousand shares) Q3 2020
Avg closing price $18.73
Price range $14.78 - $22.49
Increased shares by 735.9% (+151 Thousand shares) Q2 2020
Avg closing price $25.69
Price range $20.64 - $30.69
Sold 4.4% shares (-948 shares) Q1 2020
Avg closing price $25.03
Price range $17.84 - $31.21
New holding (+21.4 Thousand shares) Q4 2019
Avg closing price $19.43
Price range $16.12 - $25.89
Sold -17.4 Thousand shares Q3 2019
Avg closing price $20.20
Price range $16.51 - $23.78
Sold 79.5% shares (-67.3 Thousand shares) Q2 2019
Avg closing price $20.26
Price range $15.60 - $25.15
Increased shares by 179.8% (+54.5 Thousand shares) Q1 2019
Avg closing price $25.36
Price range $22.57 - $28.15
Increased shares by 43.7% (+9.21 Thousand shares) Q4 2018
Avg closing price $27.00
Price range $22.52 - $35.07
Sold 35.7% shares (-11.7 Thousand shares) Q3 2018
Avg closing price $27.25
Price range $22.83 - $32.67
New holding (+32.8 Thousand shares) Q2 2018
Avg closing price $23.74
Price range $22.06 - $25.52

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!